Please ensure Javascript is enabled for purposes of website accessibility

Nephron Pharmaceuticals announces new president of 503B outsourcing

Christina Lee Knauss //June 9, 2023//

Nephron Pharmaceuticals announces new president of 503B outsourcing

Christina Lee Knauss //June 9, 2023//

Listen to this article

Nephron Pharmaceuticals has named Christopher Fortier as president of its 503B Outsourcing Facility.In his new role, Fortier will oversee all operations at the facility that produces sterile medications for hospitals and medical facilities across the country in an effort to alleviate drug shortage needs.  

“Chris has not only the education and skill, but also the knowledge of what major hospitals and pharmacies around the country need every day,” said Nephron CEO and Owner Lou Kennedy. “That combination will be an invaluable asset to the Nephron team.” 

Prior to joining Nephron, Fortier was the chief pharmacy officer at Massachusetts General Hospital in Boston. He was responsible for leading all aspects of Mass General’s pharmacy enterprise. He chaired the Mass General Brigham Chief Pharmacy Officer’s Council and was responsible for leading large-scale pharmacy initiatives at the health system level.   

Fortier has served in healthcare leadership roles for numerous state and national professional organizations, has been published in multiple healthcare journals, and has been featured in a variety of media outlets including NBC Nightly News, the Associated Press, the Wall Street Journal and National Public Radio.

He holds a doctorate in pharmacy from the University of Connecticut and completed a PGY-1/PGY-2 Health-System Pharmacy Administration Residency at the Medical University of South Carolina Medical Center in Charleston.

He has given over 100 national and international presentations, is a course coordinator at Harvard Medical School and has academic appointments at the University of North Carolina – Chapel Hill, the University of Connecticut, and Northeastern University.


 Based in West Columbia, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company’s 503B Outsourcing Facility produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals.